[go: up one dir, main page]

WO2012059343A1 - Composition sous forme de poudre comprenant au moins une huile essentielle et une fécule de manioc modifiée - Google Patents

Composition sous forme de poudre comprenant au moins une huile essentielle et une fécule de manioc modifiée Download PDF

Info

Publication number
WO2012059343A1
WO2012059343A1 PCT/EP2011/068457 EP2011068457W WO2012059343A1 WO 2012059343 A1 WO2012059343 A1 WO 2012059343A1 EP 2011068457 W EP2011068457 W EP 2011068457W WO 2012059343 A1 WO2012059343 A1 WO 2012059343A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
composition according
starch
acid
essential oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/068457
Other languages
English (en)
Inventor
Olga Biganska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2012059343A1 publication Critical patent/WO2012059343A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D33/00—Containers or accessories specially adapted for handling powdery toiletry or cosmetic substances
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D33/00—Containers or accessories specially adapted for handling powdery toiletry or cosmetic substances
    • A45D33/02—Containers or accessories specially adapted for handling powdery toiletry or cosmetic substances with dispensing means, e.g. sprinkling means
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D33/00—Containers or accessories specially adapted for handling powdery toiletry or cosmetic substances
    • A45D33/34—Powder-puffs, e.g. with installed container
    • A45D33/36—Powder-puffs, e.g. with installed container with handle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material

Definitions

  • composition in the powder form comprising, in a cosmetically acceptable particulate phase:
  • the present invention thus relates to a method for the cosmetic treatment of body odours, in particular axillary odours, which consists in applying, to the skin, in particular the axillae, a composition as defined above.
  • the commonest deodorant compositions on the cosmetics market are provided in the roll-on form, the stick form or in the form pressurized in a device of the aerosol type with propellant or vaporizer (spray).
  • each of these types of presentation forms exhibits disadvantages and discomforts for the user.
  • Roll-ons exhibit the inconvenience of producing a wet feeling and of having a long drying time. Aerosols and sprays have the disadvantage of producing a sternutatory effect on the consumer.
  • amylose and amylopectin vary according to the botanical source of the starches.
  • the amylose/amylopectin ratio by weight can vary from 30/70 (maize) to 16/84 (rice).
  • These starting materials are often combined with other compounds in order to form more or less occlusive films on the skin.
  • the need remains to produce cosmetic or dermatological compositions in the powder form based on polysaccharides having a good deodorant effectiveness without the disadvantages indicated above, such as an excessively long drying time, the feeling of discomfort or a phenomenon of fluffing.
  • the Applicant Company has discovered, surprisingly, that this objective can be achieved by using an essential oil or a mixture of essential oils in a powder in combination with (a) at least one modified tapioca starch exhibiting an absorption capacity for a fatty substance of greater than 1 ml/g.
  • the Applicant Company has also found, unexpectedly, that such a powder makes it possible not only to obtain a good deodorant effectiveness but also an antiperspirant activity. This discovery is at the basis of the present invention.
  • the present invention thus relates to a composition in the powder form comprising, in a cosmetically acceptable particulate phase:
  • cosmetically acceptable is understood here to mean any support compatible with the skin and/or its superficial body growths which exhibits a pleasant colour, a pleasant odour and a pleasant feel and which does not cause unacceptable discomfort (smartness, tightness, redness) liable to dissuade the consumer from using this composition.
  • modified starch is understood to mean any starch which has been subjected to a transformation by the chemical, physical or enzymatic route.
  • the fatty substances are composed of oils and waxes.
  • oil is understood to mean a compound which is liquid at ambient temperature.
  • wax is understood to mean a compound which is solid or substantially solid at ambient temperature and which has a melting point generally of greater than 35°C.
  • compositions in accordance with the invention exhibit a good bactericidal effectiveness with regard to the microorganisms involved in the formation of unpleasant axillary odours, predominantly Cory nebacteri urn xerosis, and can thus be used as deodorant product.
  • the present invention thus relates to a method for the cosmetic treatment of body odours, in particular axillary odours, which consists in applying, to the skin, in particular the axillae, a composition as defined above.
  • an essential oil is an odorous product generally of complex composition which is obtained from a botanically defined plant starting material, either by steam distillation or by dry distillation or by an appropriate mechanical process devoid of heating (cold expression).
  • the essential oil is generally separated from the aqueous phase by a physical process not resulting in a significant change in the composition.
  • essential oils The choice of technique depends mainly on the starting material: its original state and its characteristics, its nature proper.
  • the "essential oil/plant starting material” yield can be highly variable depending on the plants: 15 ppm to more than 20%. This choice conditions the characteristics of the essential oil, in particular viscosity, colour, solubility, volatility, enrichment or depletion in some constituents.
  • Steam distillation corresponds to the vaporization, in the presence of steam, of a substance which is not very miscible with water.
  • the starting material is brought together with water brought to boiling point or with steam in a still.
  • the steam entrains the essential oil vapour, which is condensed in the condenser in order to be recovered as liquid phase in a Florentine flask (or essence jar), where the essential oil is separated from the water by settling.
  • the term "aromatic water” or “hydrolat” or "distilled floral water” is used to describe the aqueous distillate which remains after the steam distillation, once the essential oil has been separated.
  • the essential oil is obtained by distillation of the wood, bark or roots, without addition of water or steam, in a closed chamber designed in order for the liquid to be recovered in its bottom part.
  • Cade oil is the most well known example of this method of production. Cold expression
  • This method of production is applied only to citrus fruit (Citrus spp.) by mechanical processes at ambient temperature.
  • the principle of the method is as follows: the peel is shredded and the contents of the secretory cavities which have been ruptured are recovered by a physical process.
  • the conventional process consists in exerting an abrasive action over the entire surface of the fruit under a stream of water. After removing the solid waste, the essential oil is separated from the aqueous phase by centrifuging.
  • the majority of industrial plants in fact allow the simultaneous or sequential recovery of the fruit juices and of the essential oil.
  • Essential oils are generally volatile and liquid at ambient temperature, which differentiates them from “fixed oils”. They are more or less coloured and their density is generally lower than that of water. They have a high refractive index and the majority deviate polarized light. They are soluble in fats and in standard organic solvents, can be steam distilled and exhibit a very low solubility in water.
  • They are composed of molecules comprising a carbon-based backbone, the number of carbon atoms generally being between 5 and 22.
  • the main chemical categories of compounds present in essential oils are:
  • turpentine essential oil -pinene, camphene
  • juniper essential oil -pinene, camphene, cadinene
  • coriander essential oil linalool
  • lavender essential oil linalool and linalyl acetate
  • mint essential oil menthol and menthyl acetate.
  • cinnamon essential oil cinnamon essential oil: cinnamaldehyde
  • citronella essential oil citral and citronellal
  • Eucalyptus citriodora essential oil citronellal.
  • caraway essential oil carvone
  • thuja essential oil thujone
  • oregano essential oil thymol and carvacrol
  • clove essential oil eugenol.
  • aniseed essential oil or star anise essential oil anethole
  • Eucalyptus globulus essential oil eucalyptol
  • cajuput essential oil eucalyptol
  • niaouli essential oil eucalyptol
  • garlic essential oil allicin.
  • the great majority of essential oils are composed of a complex mixture of compounds belonging to these different chemical families.
  • Plant starting materials used to produce the essential oils are generally plants or plant parts which are in various states of dryness (dry, withered or fresh form).
  • Apiaceae for example umbellifers: dill, angelica, coriander, sea fennel, carrot, parsley
  • Asteraceae Achillea, Artemisia, camomile, Helichrysum
  • Geraniaceae geranium
  • Hypericaceae St. John's wort
  • Lamiaceae thyme, oregano, Monarda, savory, basil, marjorams, mints, patchouli, lavenders, sages, catnip, rosemary, hyssop, balm
  • Magnoliaceae magnolia
  • Myrtaceae eucalyptus, tea tree, Melaleuca quinquenervia, cajuput, Backhousia, clove, myrtle
  • Rosaceae roses Rubiaceae
  • Thymelaceae agarwood
  • Verbenaceae lantana, verbena
  • Zingiberaceae galangal, turmeric, cardamom, ginger
  • the essential oil or oils used according to the invention will be present in concentrations preferably ranging from 0.001 % to 10% by weight, with respect to the total weight of the composition, and more preferably from 0.1 % to 6% by weight, with respect to the total weight of the composition.
  • the particulate phase in accordance with the invention comprises at least one filler other than the modified tapioca starch exhibiting an absorption capacity for a fatty substance of greater than 1 ml/g.
  • filler should be understood as meaning colourless or white and inorganic or synthetic particles of any shape which are insoluble in the medium of the composition, whatever the temperature at which the composition is manufactured.
  • the filler or fillers are present in concentrations preferably ranging from 50 to 99% by weight and more preferably from 75 to 99% by weight and more preferably still from 80 to 99% by weight, with respect to the total weight of the composition.
  • the filler can be composed of spherical particles, of lamellar particles or of a mixture of spherical particles and of lamellar particles.
  • spherical particles is understood to mean, in the present patent application, particles having the shape or substantially the shape of a sphere which are insoluble in the medium of the composition according to the invention, even at the melting point of the medium (approximately 100°C).
  • lamellar particles is understood here to mean particles of parallelepipedal shape (rectangular or square surface), discoidal shape (circular surface) or ellipsoidal shape (oval surface) characterized by three dimensions: a length, a width and a height, which particles are insoluble in the medium of the composition according to the invention, even at the melting point of the medium (approximately 100°C).
  • the spherical particles used according to the invention have the shape or substantially the shape of a sphere and can be hollow or solid.
  • the particles of the invention have a particle size (number-average diameter) ranging from 0.1 pm to 250 pm, better still from 1 pm to 150 pm and better still from 10 pm to 100 pm.
  • the spherical particles can be organic or inorganic microspheres. Mention may be made, as spherical particles which can be used in the composition of the invention, for example, of silica powder; polyamide particles and in particular particles of Nylon 12, such as that sold under the name Orgasol by Atochem; polyethylene powders; microspheres based on acrylic copolymers, such as those made of ethylene glycol dimethacrylate/lauryl methacrylate copolymer sold by Dow Corning under the Polytrap name; expanded powders, such as hollow microspheres and in particular the polyvinylidene chloride/acrylonitrile microspheres sold under the name Expancel by Kemanord Plast or under the name Micropearl F 80 ED by Matsumoto; natural organic powders, such as bamboo powders, for example sold by Draco Natural Products; native starch powders or modified starch powders other than that of tapioca of the invention; silicone resin microbeads, especially silsesquioxan
  • starches used other than that of modified tapioca as described above, may be unmodified (native) or modified by the chemical or physical route.
  • unmodified or native starch is understood to mean any starch which has not been subjected to chemical, physical or enzymatic transformation.
  • additional starches can have, as botanical origin, cereals or tubers.
  • the natural starches can be chosen from maize, rice, tapioca, cassava, barley, potato, wheat, sorghum, palm or pea starches.
  • unmodified rice starches such as the commercial product sold under the trade name Remi DR I by Beneo-Remy, or maize starches (INCI name: Zea Mays Starch) such as the product sold under the trade name C Gel 04201 by Cargill or such as the products sold under the Farmal CS trade names, in particular the commercial product Farmal CS 3650, by Corn Products International.
  • the additional modified starches of the invention can be modified by crosslinking with functional agents capable of reacting with the hydroxyl groups of the starch molecules, which will thus be bonded to one another (for example with octenylsuccinate anhydride, glyceryl and/or phosphate groups).
  • X denotes in particular alkali metals (for example sodium or potassium), alkaline earth metals (for example calcium or magnesium), ammonium ion, amine, such as those of monoethanolamine, diethanolamine, triethanolamine or 3-amino-1 ,2- propanediol, or basic amino acids, such as lysine, arginine, sarcosine, ornithine or citrulline.
  • alkali metals for example sodium or potassium
  • alkaline earth metals for example calcium or magnesium
  • ammonium ion amine
  • amine such as those of monoethanolamine, diethanolamine, triethanolamine or 3-amino-1 ,2- propanediol
  • basic amino acids such as lysine, arginine, sarcosine, ornithine or citrulline.
  • the phosphorus-comprising compounds can be, for example, sodium tripolyphosphate, sodium orthophosphate, phosphorus oxychloride or sodium trimetaphosphate. Mention may be made, by way of example, of starches crosslinked by octenylsuccinate anhydride, sold under the name Dry-Flo by National Starch, distarch phosphates or compounds rich in distarch phosphate, in particular the hydroxypropyl ethers of distarch phosphate having the INCI name: Hydroxypropyl Starch Phosphate, such as the products sold under the trade names Farinex VA70 C or Farmal MS 689 by Avebe Stadex; the products sold under the trade names Structure BTC, Structure HVS, Structure XL or Structure Zea by National Starch (maize distarch phosphate). Lamellar particles
  • the lamellar particles are particles of parallelepipedal shape (rectangular or square surface), discoidal shape (circular surface) or ellipsoidal shape (oval surface) characterized by three dimensions: a length, a width and a height.
  • the shape is circular, the length and the width are identical and correspond to the diameter of a disc, while the height corresponds to the thickness of the disc.
  • the surface is oval, the length and the width correspond respectively to the major axis and to the minor axis of an ellipse and the height corresponds to the thickness of the elliptical disc formed by the platelet.
  • the length and the width can be of identical or different dimensions: when they are of the same dimension, the shape of the surface of the parallelepiped is square; in the contrary case, the shape is rectangular. With regard to the height, it corresponds to the thickness of the parallelepiped.
  • the length of the lamellar particles used according to the invention preferably ranges from 0.01 to 100 pm, better still from 0.1 to 50 pm and even better still from 1 to 50 pm.
  • the width of these platelets preferably ranges from 0.01 to 100 pm, better still from 0.1 to 50 pm and even better still from 1 to 10 pm.
  • the height (thickness) of these platelets preferably ranges from 0.1 nm to 1 m (0.1 to 1000 nm), better still from 1 nm to 600 nm and even better still from 1 nm to 500 nm.
  • Lamellar silicates as lamellar particles can be used in the composition of the invention.
  • Clays are mixed silicates of natural or synthetic origin including several (two or more) types of cations chosen from alkali metals (for example Na, Li or K), alkaline earth metals (for example Be, Mg or Ca), transition metals and aluminium.
  • clays which can be used in the invention for example, of sodium magnesium silicate (CTFA name), clays of the kaolin family, such as kaolin or kaolinite, dickite or nacrite; clays of the family of halloysite, donbassite, antigorite, berthierine or pyrophyllite; montmorillonites; beidellite; vermiculites; stevensite; hectorites; saponites; chlorites; sepiolite or smectite, and also these clays chemically modified, for example by acrylic acids, polysaccharides (for example carboxymethylcellulose) or organic cations, and their mixtures.
  • CFA name sodium magnesium silicate
  • clays of the kaolin family such as kaolin or kaolinite, dickite or nacrite
  • clays of the family of halloysite, donbassite, antigorite, berthierine or pyrophyllite montmorillonites; beidellite; vermiculites; stevensite
  • Talcs are hydrated magnesium silicates generally comprising aluminium silicate.
  • the crystalline structure of talc consists of repeated layers of a sandwich of brucite between silica layers.
  • Micas are aluminium silicates optionally comprising iron and/or alkali metals. They have the property of being able to split up into thin layers (approximately 1 pm). They generally have a dimension ranging from 5 to 150 pm, preferably from 10 to 100 pm and better still from 10 to 60 pm, for the greatest dimension (length), and a height (thickness) of 0.1 to 0.5 pm. Mention may be made, as micas, of phlogopite, muscovite, fluorophlogopite, vermiculite and their mixtures. Mention may also be made of micaceous clays, such as illite.
  • pearlescent agents should be understood as meaning iridescent particles, in particular produced by certain shellfish in their shells or else synthesized, which are used to modify the texture of the composition and the mattness/sheen effect.
  • Pearlescent agents are generally micas surface-treated in order to obtain this iridescent effect. Mention may be made, among the pearlescent agents which can be used in the invention, for example, of micas covered with titanium oxide, with iron oxide, with natural pigment and/or with bismuth oxychloride, such as coloured or colourless mica/titanium oxide (or titanium oxide-coated mica), and their mixtures. Mention may also be made, among lamellar silicates, of perlites and preferably expanded perlites.
  • the perlites which can be used according to the invention are generally aluminosilicates of volcanic origin and have the composition:
  • perlite is milled, dried and then graded in a first stage.
  • the product obtained, referred to as perlite ore is grey in colour and has a size of the order of 100 pm.
  • the perlite ore is subsequently expanded (1000°C/2 seconds) to give more or less white particles.
  • the temperature reaches 850-900°C, the water trapped in the structure of the material is vaporized and brings about the expansion of the material with respect to its original volume.
  • the expanded perlite particles in accordance with the invention can be obtained by the expansion process described in Patent US 5 002 698.
  • the perlite particles used will be milled; they are in this case referred to as Expanded Milled Perlite (EMP). They preferably have a particle size defined by a median diameter D 50 ranging from 0.5 to 50 pm and preferably from 0.5 to 40 pm.
  • EMP Expanded Milled Perlite
  • the perlite particles used exhibit a loose bulk density at 25°C ranging from 10 to 400 kg/m 3 (Standard DIN 53468) and preferably from 10 to 300 kg/m 3
  • the expanded perlite particles according to the invention have a water absorption capacity, measured at the wet point, ranging from 200 to 1500% and preferably from 250 to 800%.
  • the wet point corresponds to the amount of water which it is necessary to add to 1 g of particles in order to obtain a homogeneous paste.
  • This method is derived directly from that of the oil uptake applied to solvents.
  • the measurements are carried out in the same way via the wet point and the flow point, which respectively have the following definitions: wet point: weight, expressed in grams per 100 g of product, corresponding to the achievement of a homogeneous paste during the addition of a solvent to a powder; flow point: weight, expressed in grams per 100 g of product, starting from which the amount of solvent is greater than the capacity of the powder to retain it. This is reflected by the achievement of a more or less homogeneous mixture which flows over the glass plate.
  • the lamellar particles will be chosen from an expanded perlite, sodium magnesium silicate, kaolin, kaolinite, a montmorillonite, a hectorite, a talc, a mica, a pearlescent agent and their mixtures.
  • the lamellar particles will be chosen from expanded perlite, kaolin, a talc or their mixtures.
  • lamellar particles of kaolin, such as the product sold under the name Coslin C-100 by Engelhard; talc, such as those sold under the names Rose Talc and Talc SG-2000 by Nippon Talc; mica, such as those sold under the names Mica M RP and Silk Mica by Merck; titanium oxide-coated micas, such as the mica/titanium oxide/brown iron oxide (CTFA: Mica/Iron oxides/Titanium dioxide) sold under the name Cloisonne rouge flambe 440 X by Engelhard; a modified hectorite, such as, for example, a bentone; or expanded perlite (INCI name: Expanded Milled Perlite), such as sold under the name Optimat 1430 OR by World Minerals.
  • These lamellar particles can be present in amounts preferably ranging from 40 to 100% by weight, more preferably from 50 to 91 % by weight and better still from 60% to 80%
  • the particulate phase of the composition according to the invention can comprise pigments.
  • pigments should be understood as meaning inorganic or organic particles which are insoluble in the liquid organic phase and which are intended to colour and/or opacify the composition.
  • the pigments can be inorganic or organic pigments.
  • Use may be made, as pigments, of metal oxides, such as iron oxides (in particular those which are yellow, red, brown or black in colour), titanium dioxides, cerium oxide, zirconium oxide or chromium oxide; manganese violet, ultramarine blue, Prussian blue, ferric blue and their mixtures.
  • Use is preferably made of pigments formed of iron oxides or of titanium dioxide.
  • the pigments can be treated with a hydrophobic agent in order to render them compatible with the organic phase of the composition.
  • the hydrophobic treatment agent can be chosen from silicones, such as methicones, dimethicones or perfluoroalkylsilanes; fatty acids, such as stearic acid; metal soaps, such as aluminium dimyristate or the aluminium salt of hydrogenated tallow glutamate; perfluoroalkyl phosphates, perfluoroalkylsilanes, perfluoroalkylsilazanes, poly(hexafluoropropylene oxide)s, polyorganosiloxanes comprising perfluoroalkyl perfluoropolyether groups, amino acids; N-acylated amino acids or their salts; lecithin, isopropyl triisostearyl titanate, and their mixtures.
  • the N-acylated amino acids can comprise an acyl group having from 8 to 22 carbon atoms, such as, for example, a 2-ethylhexanoyl, caproyl, lauroyl, myristoyl, palmitoyl, stearoyl or cocoyl group.
  • the salts of these compounds can be aluminium, magnesium, calcium, zirconium, zinc, sodium or potassium salts.
  • the amino acid can, for example, be lysine, glutamic acid or alanine.
  • alkyl denotes in particular an alkyl group having from 1 to 30 carbon atoms, preferably having from 5 to 16 carbon atoms.
  • the particulate phase of the invention can comprise dyes.
  • the composition according to the invention can also comprise water- or fat- soluble dyes.
  • fat-soluble dyes should be understood as meaning compounds, generally organic compounds, which are soluble in fatty substances, such as oils.
  • the fat-soluble dyes are, for example, Sudan red, D&C Red No. 17, D&C Green No. 6, ⁇ -carotene, soybean oil, Sudan brown, D&C Yellow No. 1 1 , D&C Violet No. 2, D&C Orange No. 5, quinoline yellow, annatto or bromo acids.
  • the particulate phase comprises at least one unmodified starch as described above and more particularly an unmodified rice starch, such as the commercial product sold under the trade name Remi DR I by Beneo-Remy, or a maize starch (INCI name: Zea Mays Starch), such as the product sold under the trade name C Gel 04201 by Cargill, or such as the products sold under the Farmal CS trade names, in particular the commercial product Farmal CS 3650 by Corn Products International.
  • an unmodified rice starch such as the commercial product sold under the trade name Remi DR I by Beneo-Remy
  • a maize starch such as the product sold under the trade name C Gel 04201 by Cargill
  • Farmal CS trade names in particular the commercial product Farmal CS 3650 by Corn Products International.
  • the unmodified starch or starches can preferably represent from 10 to 95% by weight, preferably from 20 to 90% by weight, with respect to the total weight of the composition.
  • One of the essential ingredients of the composition in the powder form according to the invention is a modified tapioca starch exhibiting an absorption capacity for a fatty substance of greater than 1 ml/g.
  • the absorption capacity for a fatty substance varies from 2 to 6 ml/g.
  • the fatty substance absorption capacity can be measured according to the method described below:
  • tip 1 mm
  • the modified tapioca starch will be present in the powder of the invention preferably at contents ranging from 0.1 to 10% by weight and more preferably from 0.5 to 5% by weight, with respect to the total weight of the composition.
  • compositions of the invention used for the treatment of body odours can additionally comprise at least one agent for the treatment of perspiration.
  • agent for the treatment of perspiration is understood to mean any substance which, by itself alone, has the effect of reducing the feeling of moisture on the skin related to human sweat or of masking human sweat.
  • the antiperspirant salts or complexes in accordance with the invention are generally chosen from aluminium and/or zirconium salts or complexes. They are preferably chosen from aluminium hydrohalides; aluminium zirconium hydrohalides, or complexes of zirconium hydroxychloride and of aluminium hydroxychloride, with or without an amino acid, such as those described in Patent US-3 792 068.
  • aluminium salts of aluminium chlorohydrate in the activated or nonactivated form
  • aluminium chlorohydrex the aluminium chlorohydrex polyethylene glycol complex
  • aluminium chlorohydrex propylene glycol complex aluminium dichlorohydrate
  • aluminium dichlorohydrex polyethylene glycol complex aluminium dichlorohydrex propylene glycol complex
  • aluminium sesquichlorohydrate aluminium sesquichlorohydrex polyethylene glycol complex
  • aluminium sesquichlorohydrex propylene glycol complex aluminium sesquichlorohydrate
  • aluminium sesquichlorohydrex polyethylene glycol complex aluminium sesquichlorohydrex propylene glycol complex
  • aluminium sesquichlorohydrex propylene glycol complex aluminium sulphate buffered with sodium aluminium lactate.
  • aluminium zirconium salts of aluminium zirconium octachlorohydrate, aluminium zirconium pentachlorohydrate, aluminium zirconium tetrachlorohydrate or aluminium zirconium trichlorohydrate.
  • the complexes of zirconium hydroxychloride and of aluminium hydroxychloride with an amino acid are generally known under the name ZAG (when the amino acid is glycine). Mention may be made, among these products, of the aluminium zirconium octachlorohydrex glycine, aluminium zirconium pentachlorohydrex glycine, aluminium zirconium tetrachlorohydrex glycine and aluminium zirconium trichlorohydrex glycine complexes.
  • the antiperspirant active principles can be present in the composition according to the invention in a proportion of approximately 0.5 to 25% by weight, with respect to the total weight of the composition.
  • the compositions according to the invention can also comprise, in addition, one or more additional deodorant active principles.
  • deodorant active principle is used to describe any substance capable of masking, absorbing, improving and/or reducing the unpleasant odour resulting from the decomposition of human sweat by bacteria.
  • the deodorant active principles can be bacteriostatic agents or bactericidal agents acting on the microorganisms of axillary odours, such as 2,4,4'-trichloro-2'- hydroxydiphenyl ether ( ® Triclosan), 2,4-dichloro-2'-hydroxydiphenyl ether, 3',4',5'- trichlorosalicylanilide, 1 -(3',4'-dichlorophenyl)-3-(4'-chlorophenyl)urea
  • 2,4,4'-trichloro-2'- hydroxydiphenyl ether ® Triclosan
  • 2,4-dichloro-2'-hydroxydiphenyl ether 2,4-dichloro-2'-hydroxydiphenyl ether
  • 3',4',5'- trichlorosalicylanilide 1 -(3',4'-dichlorophenyl)-3-(4'-chloroph
  • ® Triclocarban or 3,7, 1 1 -trimethyldodeca-2, 5, 10-trienol ( ® Farnesol); quaternary ammonium salts, such as cetyltrimethylammonium salts or cetylpyridinium salts, DPTA (1 ,3-diaminopropanetetraacetic acid), 1 ,2-decanediol (Symclariol from Symrise), biguanide derivatives, such as polyhexamethylene biguanide salts or chlorhexidine and its salts; or 4-phenyl-4,4-dimethyl-2-butanol (Symdeo MPP from Symrise).
  • quaternary ammonium salts such as cetyltrimethylammonium salts or cetylpyridinium salts, DPTA (1 ,3-diaminopropanetetraacetic acid), 1 ,2-decanediol (Symclariol from Symrise), bigu
  • zinc salts such as zinc salicylate, zinc gluconate, zinc pidolate
  • zinc sulphate zinc chloride
  • zinc lactate zinc phenolsulphonate or zinc ricinoleate
  • the deodorant active principles can preferably be present in the compositions according to the invention in concentrations by weight ranging from 0.01 to 5% by weight, with respect to the total weight of the composition. According to a specific form of the invention, in order to improve the deodorant effectiveness of the composition, it is possible to add a hydroxylated ester resulting from the esterification of polyol and of C4-C16 carboxylic acid(s).
  • esters more particularly considered according to the present invention are hydroxylated esters resulting from the esterification of polyol and of C 4 to Cie, more particularly Ce to C12, in particular C 7 to C10 and more particularly Cs to C9 carboxylic acid(s).
  • esters used according to the invention are in a hydroxylated form, that is to say carry at least one hydroxyl functional group, preferably 2, indeed even 3 or more, the hydroxyl functional groups being present on the alcohol residue of the ester.
  • the esters are C10 to C20 esters and have at least one fatty chain.
  • the esters suitable for the present invention can derive from the esterification of a polyol by various carboxylic acids, with the proviso, of course, that the ester thus obtained has at least one and preferably two free hydroxyl functional groups. It can be a hydroxylated monoester, a hydroxylated diester or one of their mixtures.
  • polyol is understood to mean, within the meaning of the invention, any organic molecule comprising, in its chemical structure, at least two hydroxyl (OH) groups.
  • the polyol can in particular be a saturated or unsaturated and linear, branched or cyclic hydrocarbon compound carrying at least two and in particular at least three OH functional groups.
  • the polyol can in particular be a hydrocarbon compound comprising at least 2 carbon atoms and preferably less than 15 carbon atoms and carrying at least two hydroxyl groups, preferably from 2 to 10 hydroxyl groups.
  • It is preferably a hydrocarbon compound having from 2 to 12 carbon atoms and more preferably still from 2 to 8 carbon atoms.
  • the polyol can be a compound having from 2 to 8 carbon atoms and from 2 to 6 hydroxyl functional groups, such as, for example, ethylene glycol, glycerol, 1 ,2,3- trihydroxyhexane, butanediol, 1 ,2-propanediol, erythritol, arabitol, adonitol, dulcitol, pentanediols, in particular 1 ,2-pentanediol, sorbitol or their mixtures.
  • hydroxyl functional groups such as, for example, ethylene glycol, glycerol, 1 ,2,3- trihydroxyhexane, butanediol, 1 ,2-propanediol, erythritol, arabitol, adonitol, dulcitol, pentanediols, in particular 1 ,2-pentanediol, sorbitol or their mixture
  • Glycerol derivatives are, for example, butyl diglycol, polyglyceryl-3 diisostearate and castor oil.
  • the polyol can be chosen from glycerol polymers and copolymers, such as, for example, hexaglycerol and diglycerol.
  • Glycol examples are, for example, ethylene glycol, propylene glycol, hexylene glycol, isoprene glycol, butylene glycol and pentylene glycol and those defined above.
  • the polyol can also be chosen from sugars, such as glucose, fructose, xylose, trehalose, sucrose, maltose, lactose and their mixtures. Use may also be made of a mixture of polyols.
  • the polyol used according to the invention can more particularly be chosen from glycerol, glycols and their derivatives.
  • the particularly preferred polyols are chosen from glycerol, 1 ,2-propylene glycol or a mixture of two or more of these polyols.
  • Carboxylic acid The carboxylic acid can be saturated or unsaturated and linear or branched. It is advantageously a linear monocarboxylic acid.
  • monocarboxylic acid suitable for the invention of butanoic acid, pentanoic acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, undecanoic acid, dodecanoic acid, tridecanoic acid, tetradecanoic acid, heptadecanoic acid, hexadecanoic acid or pentadecanoic acid
  • Hydroxy acids are also suitable for the present invention, such as 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyheptanoic acid, 2-hydroxyoctanoic acid, 2-hydroxynonanoic acid, 2-hydroxydecanoic acid, 2-hydroxyundecanoic acid, 2-hydroxydodecanoic acid, 2-hydroxytridecanoic acid, 2-hydroxytetradecanoic acid and 2-hydroxyhexadecanoic acid.
  • esters chosen from mono- and/or diglyceryl caprylate, mono- and/or diglyceryl heptanoate, mono- and/or diglyceryl caprylate, propylene glycol caprylate, propylene glycol heptanoate and their mixtures are very particularly suitable for the invention.
  • the ester or esters can be present in the composition of the invention at a content preferably varying from 0.1 to 5% by weight, more preferably from 0.5 to 3% by weight and more particularly from 1 to 2% by weight of the total weight of the composition.
  • the compositions in accordance can be packaged in and dispensed from a device of "saltcellar" type provided with a container comprising the composition and surmounted by a dispensing opening, in particular a dispensing grid comprising a plurality of holes; this opening being able to be attached by a fastening ring which is connected to the container by any appropriate means, such as screwing, snapping or crimping, and generally comprising a cap which will reversibly close the said dispensing opening by any appropriate means, such as screwing or snapping.
  • the said dispensing opening can be covered with an intermediate protective cover.
  • the device and its various components will preferably be formed from polymer of the polyolefin type, such as polyethylene or polypropylene.
  • the wall of the container can be flexible or rigid.
  • Another subject-matter of the invention consists of such a packaging and dispensing device comprising a composition according to the invention as defined above.
  • the compositions in accordance can be packaged in the form of single-dose bags.
  • the composition of the invention can be packaged in an applicator comprising a reservoir containing the said composition, a cap intended to close the reservoir and an applicator holder which supports a deformable component for application of the product, made of foam or of elastomer of low hardness, the deformable component carrying bumps at the surface and having a high shape memory.
  • the reservoir is bounded by a capillary end piece in the form of a thimble having a far end equipped with a seat pierced by at least one capillary orifice against which the deformable component is applied and deformed in the position of closure of the reservoir by the cap.
  • a capillary end piece in the form of a thimble having a far end equipped with a seat pierced by at least one capillary orifice against which the deformable component is applied and deformed in the position of closure of the reservoir by the cap.
  • the composition of the invention can be packaged in a device as described in Application EP 1 086 904. It is a packaging device comprising a container having an interior space in which the composition of the invention in the powder form is present, a housing for receiving the application component and a permeable wall positioned between the said housing and the interior space containing the composition, the application component and the housing being arranged so that the application component exhibits, when it is in the said housing, at least one surface portion situated without substantial axial compression, with regard to an opening in the permeable wall, the said interior space being variable in volume.
  • compression means are provided in order to selectively change the said interior volume from a first volume, greater than the volume of the composition, to a second volume, lower than the first, this reduction in volume being accompanied by an excess pressure, which is capable of promoting the transfer of composition through the said permeable wall to the application component.
  • Example 1 Deodorant powder

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention porte sur une composition sous forme de poudre comprenant, dans une phase particulaire cosmétiquement acceptable : a) au moins une huile essentielle ou un mélange d'huiles essentielles ; b) au moins une fécule de manioc modifiée présentant une capacité d'absorption pour une substance grasse de plus de 1 ml/g ; c) au moins une charge autre que ladite fécule. La présente invention porte ainsi sur un procédé pour le traitement cosmétique d'odeurs corporelles, en particulier d'odeurs axillaires, lequel procédé consiste à appliquer, sur la peau, en particulier les aisselles, une composition telle que définie ci-dessus.
PCT/EP2011/068457 2010-11-05 2011-10-21 Composition sous forme de poudre comprenant au moins une huile essentielle et une fécule de manioc modifiée Ceased WO2012059343A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1059139A FR2967060B1 (fr) 2010-11-05 2010-11-05 Composition sous forme de poudre comprenant au moins une huile essentielle, un amidon de tapioca modifie
FR1059139 2010-11-05
US41121710P 2010-11-08 2010-11-08
US61/411,217 2010-11-08

Publications (1)

Publication Number Publication Date
WO2012059343A1 true WO2012059343A1 (fr) 2012-05-10

Family

ID=44237148

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/068457 Ceased WO2012059343A1 (fr) 2010-11-05 2011-10-21 Composition sous forme de poudre comprenant au moins une huile essentielle et une fécule de manioc modifiée

Country Status (2)

Country Link
FR (1) FR2967060B1 (fr)
WO (1) WO2012059343A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022666A1 (fr) * 2012-08-01 2014-02-06 Cornell University Compositions de résine réticulée d'amidon natif et cireux et procédés pour leur fabrication
KR101566293B1 (ko) 2013-11-27 2015-11-05 대한민국(농촌진흥청장) 피부촉감과 흡습성을 개선한 쌀 베이비파우더의 제조방법
CN110405893A (zh) * 2019-07-22 2019-11-05 上海洋明塑料科技有限公司 一种竹制品容器及其制备方法
EP4058154A4 (fr) * 2019-11-13 2023-12-20 Revlon Consumer Products LLC Compositions anti-transpirantes/déodorantes
CN118542822A (zh) * 2024-05-28 2024-08-27 广东迦心化妆品有限公司 一种眼影及其制备方法
GB2630130A (en) * 2023-05-18 2024-11-20 Oere Ltd Powder composition

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
US4485092A (en) * 1983-08-03 1984-11-27 Johnson & Johnson Baby Products Company Talc compositions
EP0293795A1 (fr) 1987-05-29 1988-12-07 Toshiba Silicone Company, Ltd. Composition de maquillage ou composition cosmétique
US5002698A (en) 1986-01-10 1991-03-26 Ciba-Geigy Corporation Sulfur- and nitrogen-containing lubricant additives
WO1999044566A1 (fr) * 1998-03-02 1999-09-10 The Procter & Gamble Company Poudres pour le corps hautement absorbantes
EP1086683A1 (fr) 1999-09-22 2001-03-28 L'oreal Composition de gel et son utilisation en cosmétique
EP1086904A1 (fr) 1999-09-21 2001-03-28 L'oreal Dispositif de conditionnement et d'application
WO2001066078A1 (fr) * 2000-03-08 2001-09-13 Block Drug Company, Inc. Composition cosmetique a caracteristiques ameliorees d'absorption et d'adherence
US6534046B1 (en) * 2001-08-01 2003-03-18 Coty B.V. Plant-based anti-perspiration cosmetic
WO2003105790A1 (fr) * 2002-06-17 2003-12-24 The Procter & Gamble Company Trousse de fond de teint absorbant le sebum et la sueur et procede associe en plusieurs etapes
WO2006096506A1 (fr) * 2005-03-04 2006-09-14 Steven Gordon Compositions cosmetiques, procedes d’application et de fabrication desdites compositions
US20080260786A1 (en) * 2002-08-15 2008-10-23 Solarek Daniel B Process for making encapsulated particles

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
US4485092A (en) * 1983-08-03 1984-11-27 Johnson & Johnson Baby Products Company Talc compositions
US5002698A (en) 1986-01-10 1991-03-26 Ciba-Geigy Corporation Sulfur- and nitrogen-containing lubricant additives
EP0293795A1 (fr) 1987-05-29 1988-12-07 Toshiba Silicone Company, Ltd. Composition de maquillage ou composition cosmétique
WO1999044566A1 (fr) * 1998-03-02 1999-09-10 The Procter & Gamble Company Poudres pour le corps hautement absorbantes
EP1086904A1 (fr) 1999-09-21 2001-03-28 L'oreal Dispositif de conditionnement et d'application
EP1086683A1 (fr) 1999-09-22 2001-03-28 L'oreal Composition de gel et son utilisation en cosmétique
WO2001066078A1 (fr) * 2000-03-08 2001-09-13 Block Drug Company, Inc. Composition cosmetique a caracteristiques ameliorees d'absorption et d'adherence
US6534046B1 (en) * 2001-08-01 2003-03-18 Coty B.V. Plant-based anti-perspiration cosmetic
WO2003105790A1 (fr) * 2002-06-17 2003-12-24 The Procter & Gamble Company Trousse de fond de teint absorbant le sebum et la sueur et procede associe en plusieurs etapes
US20080260786A1 (en) * 2002-08-15 2008-10-23 Solarek Daniel B Process for making encapsulated particles
WO2006096506A1 (fr) * 2005-03-04 2006-09-14 Steven Gordon Compositions cosmetiques, procedes d’application et de fabrication desdites compositions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022666A1 (fr) * 2012-08-01 2014-02-06 Cornell University Compositions de résine réticulée d'amidon natif et cireux et procédés pour leur fabrication
US9790350B2 (en) 2012-08-01 2017-10-17 Cornell University Crosslinked native and waxy starch resin compositions and processes for their manufacture
KR101566293B1 (ko) 2013-11-27 2015-11-05 대한민국(농촌진흥청장) 피부촉감과 흡습성을 개선한 쌀 베이비파우더의 제조방법
CN110405893A (zh) * 2019-07-22 2019-11-05 上海洋明塑料科技有限公司 一种竹制品容器及其制备方法
EP4058154A4 (fr) * 2019-11-13 2023-12-20 Revlon Consumer Products LLC Compositions anti-transpirantes/déodorantes
US12491152B2 (en) 2019-11-13 2025-12-09 Revlon Consumer Products Corporation Antiperspirant/deodorant compositions
GB2630130A (en) * 2023-05-18 2024-11-20 Oere Ltd Powder composition
CN118542822A (zh) * 2024-05-28 2024-08-27 广东迦心化妆品有限公司 一种眼影及其制备方法

Also Published As

Publication number Publication date
FR2967060B1 (fr) 2012-12-07
FR2967060A1 (fr) 2012-05-11

Similar Documents

Publication Publication Date Title
WO2011101239A2 (fr) Utilisations cosmétiques ou dermatologiques d'une poudre comprenant une charge, une huile essentielle et un ester hydroxylé de polyol et d'un ou plusieurs acides carboxyliques en c4 à c16
ES2866916T3 (es) Composición anhidra a base de polvo de peinado y/o absorbente de sebo y de partículas que encapsulan un agente beneficioso
WO2012059343A1 (fr) Composition sous forme de poudre comprenant au moins une huile essentielle et une fécule de manioc modifiée
RU2708202C2 (ru) Безводный распылитель дезодоранта, оборудованный полой распылительной головкой
RU2523898C2 (ru) Композиция антиперспиранта/дезодоранта
CA2741635A1 (fr) Compositions antisudorifiques anhydres renfermant des capsules de parfum sensibles a la friction
US20100196484A1 (en) Use of expanded amorphous mineral particles for increasing the tenacity of a fragrance, scenting composition and method for treating body odours
US20170189286A1 (en) Cosmetic compositions having mechanically activated warming enhancement
WO2017114786A1 (fr) Composition anti-transpirante anhydre sous forme d'aérosol comprenant un agent actif anti-transpirant et un polymère dérivé de vinylpyrrolidone
US10376450B2 (en) Anhydrous deodorant composition made from bicarbonate
US20040265254A1 (en) Antiperspirant or deodorant composition
WO2018076083A1 (fr) Composition déodorante anti-transpirantes de masquage
US10561589B2 (en) Anhydrous soft solid composition based on particles encapsulating a beneficial agent
WO2012084520A2 (fr) Utilisation de particules d'aérogel hydrophobe en tant qu'agent actif déodorant ; méthode pour le traitement des odeurs corporelles humaines
ES2793012T3 (es) Aceite anhidro a base de partículas de encapsulación de un agente beneficioso
WO2010149514A2 (fr) Compositions anti-transpirantes contenant une huile de fragrance
WO2016094974A1 (fr) Composition antisudorifique anhydre comprenant de l'huile végétale
WO2013076673A1 (fr) Composition de type émulsion stabilisée par des particules basée sur des particules de silice hydrophobes
EP2782546B1 (fr) Composition deodorante liquide de type emulsion pickering
WO2020002665A1 (fr) Composition déodorante sous forme d'aérosol
JP2005314283A (ja) 非水系粉末エアゾール
EP3226830A1 (fr) Composition anti-transpirante comprenant des cristaux liquides
RU2780567C2 (ru) Безводная композиция, содержащая соль магния
JP6907172B2 (ja) エアゾール製品
WO2012072409A2 (fr) Procédé de traitement des odeurs corporelles combinant un produit désodorisant topique et un parfum administré par voie orale; nécessaire désodorisant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11778822

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11778822

Country of ref document: EP

Kind code of ref document: A1